Ratios of pharmacological treatment for secondary prevention per region
Figure 3 shows the pharmacological treatment for secondary prevention recommended upon hospital discharge per region. The recommended ratio of the drugs for both types of infarction and in all three regions was high. The rates of RAAS inhibitor treatment for STEMI were significantly lower in the ER than in the CR (78.7% vs. 83.6%), but the ratios for beta-blocker therapy were lower in the WR than in the other two regions for both types of infarction.